Who Holds Arcutis Biotherapeutics, Inc. (ARQT)? 272 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 272 holders, $3.4 billion in total.
Largest holders
The 100 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | 12,437,000 | $326 million | +1% | 13F |
| BlackRock, Inc. | 10,545,466 | $277 million | +15% | 13F |
| Frazier Life Sciences Management, L.P. | 9,874,511 | $259 million | +0% | 13F |
| Rubric Capital Management LP | 8,271,577 | $217 million | +0% | 13F |
| Polar Capital Holdings Plc | 6,606,945 | $173 million | +17% | 13F |
| STATE STREET CORP | 5,822,840 | $153 million | -8% | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,988,756 | $131 million | +2% | 13F |
| MORGAN STANLEY | 4,451,014 | $117 million | +6% | 13F |
| JENNISON ASSOCIATES LLC | 4,219,058 | $111 million | -15% | 13F |
| D. E. Shaw & Co., Inc. | 3,949,609 | $104 million | +58% | 13F |
| UBS Group AG | 3,333,015 | $87 million | +0% | 13F |
| BANK OF AMERICA CORP /DE/ | 2,987,431 | $78 million | +34% | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 2,982,446 | $78 million | -2% | 13F |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2,429,005 | $64 million | +24% | 13F |
| ORBIMED ADVISORS LLC | 2,042,000 | $54 million | New | 13F |
| FRANKLIN RESOURCES INC | 1,930,982 | $51 million | -16% | 13F |
| AMERICAN CENTURY COMPANIES INC | 1,925,031 | $50 million | +32% | 13F |
| GOLDMAN SACHS GROUP INC | 1,668,367 | $44 million | +4% | 13F |
| Jupiter Topco LLC | 1,410,435 | $37 million | New | 13F |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,372,941 | $36 million | +1% | 13F |
| GILDER GAGNON HOWE & CO LLC | 1,313,211 | $34 million | -69% | 13F |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,265,283 | $33 million | -7% | 13F |
| BAMCO INC /NY/ | 1,253,120 | $33 million | +17% | 13F |
| CITADEL ADVISORS LLC | 1,160,014 | $30 million | +7333% | 13F |
| FEDERATED HERMES, INC. | 1,124,629 | $29 million | +4% | 13F |
| Perpetual Ltd | 1,109,657 | $29 million | +22% | 13F |
| Aberdeen Group plc | 1,098,411 | $29 million | +70% | 13F |
| Jones Hill Capital LP | 1,089,701 | $29 million | New | 13F |
| NORTHERN TRUST CORP | 1,058,575 | $28 million | +8% | 13F |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,050,934 | $28 million | +4% | 13F |
| Ensign Peak Advisors, Inc | 974,534 | $26 million | -22% | 13F |
| Candriam S.C.A. | 949,839 | $25 million | -13% | 13F |
| Driehaus Capital Management LLC | 878,426 | $23 million | -61% | 13F |
| Nuveen, LLC | 834,261 | $22 million | -8% | 13F |
| VANGUARD FIDUCIARY TRUST CO | 815,138 | $21 million | +6% | 13F |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 811,752 | $21 million | +61% | 13F |
| TWO SIGMA INVESTMENTS, LP | 663,877 | $17 million | +183% | 13F |
| FISHMAN JAY A LTD/MI | 595,005 | $16 million | +5% | 13F |
| MILLENNIUM MANAGEMENT LLC | 564,072 | $15 million | +1043% | 13F |
| BNP PARIBAS FINANCIAL MARKETS | 547,278 | $14 million | -33% | 13F |
| Squarepoint Ops LLC | 537,747 | $14 million | -51% | 13F |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | 500,000 | $13 million | +0% | 13F |
| Nearwater Capital Markets, Ltd | 486,700 | $13 million | -20% | 13F |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 466,000 | $12 million | +27% | 13F |
| MARSHALL WACE, LLP | 446,866 | $12 million | -82% | 13F |
| Privium Fund Management B.V. | 399,367 | $10 million | +24% | 13F |
| NORGES BANK | 392,300 | $10 million | New | 13F |
| DEUTSCHE BANK AG\ | 382,682 | $10 million | -2% | 13F |
| Patient Square Capital LP | 370,000 | $10 million | -8% | 13F |
| Point72 Asset Management, L.P. | 362,449 | $10 million | -39% | 13F |
| Qube Research & Technologies Ltd | 361,662 | $9 million | -50% | 13F |
| Longaeva Partners L.P. | 344,796 | $9 million | New | 13F |
| AQR CAPITAL MANAGEMENT LLC | 330,324 | $9 million | -29% | 13F |
| Bank of New York Mellon Corp | 330,094 | $9 million | +8% | 13F |
| FMR LLC | 305,969 | $8 million | +10% | 13F |
| AMERIPRISE FINANCIAL INC | 295,997 | $8 million | +191% | 13F |
| PEREGRINE CAPITAL MANAGEMENT LLC | 291,447 | $8 million | -5% | 13F |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 284,789 | $7 million | -55% | 13F |
| FIRST TRUST ADVISORS LP | 284,065 | $7 million | -19% | 13F |
| Invesco Ltd. | 264,907 | $7 million | +89% | 13F |
| Walleye Capital LLC | 260,033 | $7 million | +415% | 13F |
| Balyasny Asset Management L.P. | 243,119 | $6 million | New | 13F |
| PFM Health Sciences, LP | 242,069 | $6 million | New | 13F |
| MYDA Advisors LLC | 240,000 | $6 million | +0% | 13F |
| Jump Financial, LLC | 235,471 | $6 million | +375% | 13F |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 231,186 | $6 million | -3% | 13F |
| STATE OF WISCONSIN INVESTMENT BOARD | 230,905 | $6 million | +129% | 13F |
| Swiss National Bank | 224,000 | $6 million | +3% | 13F |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 219,815 | $6 million | +96% | 13F |
| Pictet Asset Management Holding SA | 200,275 | $5 million | +45% | 13F |
| JUPITER ASSET MANAGEMENT LTD | 202,515 | $5 million | -7% | 13F |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 199,683 | $5 million | +14% | 13F |
| Woodline Partners LP | 195,033 | $5 million | +0% | 13F |
| Pavaki Capital Management LLC | 187,000 | $5 million | +0% | 13F |
| PRINCIPAL FINANCIAL GROUP INC | 183,662 | $5 million | +9% | 13F |
| Cormorant Asset Management, LP | 175,000 | $5 million | -61% | 13F |
| RHUMBLINE ADVISERS | 170,542 | $4 million | +6% | 13F |
| Holocene Advisors, LP | 163,732 | $4 million | New | 13F |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 157,429 | $4 million | -71% | 13F |
| PDT Partners, LLC | 155,075 | $4 million | +0% | 13F |
| Vontobel Holding Ltd. | 153,242 | $4 million | +343% | 13F |
| CITIGROUP INC | 151,394 | $4 million | +213% | 13F |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 137,929 | $4 million | -11% | 13F |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 137,500 | $4 million | -4% | 13F |
| CASTLEARK MANAGEMENT LLC | 137,420 | $4 million | -53% | 13F |
| Eversept Partners, LP | 135,355 | $4 million | -77% | 13F |
| LAZARD ASSET MANAGEMENT LLC | 133,146 | $3 million | -14% | 13F |
| TUDOR INVESTMENT CORP ET AL | 131,914 | $3 million | New | 13F |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 126,258 | $3 million | -2% | 13F |
| ALLIANCEBERNSTEIN L.P. | 136,393 | $3 million | +15% | 13F |
| 1492 Capital Management LLC | 116,211 | $3 million | -2% | 13F |
| SEI INVESTMENTS CO | 114,253 | $3 million | -45% | 13F |
| Tejara Capital Ltd | 113,084 | $3 million | -32% | 13F |
| LPL Financial LLC | 111,150 | $3 million | -7% | 13F |
| WELLS FARGO & COMPANY/MN | 109,079 | $3 million | -45% | 13F |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 104,356 | $3 million | +0% | 13F |
| JPMORGAN CHASE & CO | 97,966 | $3 million | -13% | 13F |
| Legal & General Group Plc | 100,808 | $3 million | +19% | 13F |
| STEMPOINT CAPITAL LP | 98,945 | $3 million | -76% | 13F |
| Advisors Asset Management, Inc. | 95,934 | $3 million | +21% | 13F |
Questions and answers
- How many institutions hold Arcutis Biotherapeutics, Inc.?
- 272 managers reported Arcutis Biotherapeutics, Inc. on Form 13F for the quarter ended 30 June 2026, against 270 the quarter before.
- Who is the largest institutional holder of Arcutis Biotherapeutics, Inc.?
- MONTANOVA CAPITAL, LLC, with 12,437,000 shares worth $326 million on its 13F for Q2 2026.
- How many institutions bought or sold out of Arcutis Biotherapeutics, Inc. in Q2 2026?
- 42 managers reported a new position and 40 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Arcutis Biotherapeutics, Inc., Q2 2026", https://app.tamarly.ai/holders/arcutis-biotherapeutics, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.